FDA Issues Warning Over Eli Lilly Diabetes Drug Byetta
The U.S. Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly...To view the full article, register now.
Already a subscriber? Click here to view full article